Nicholas Vincent is a passionate environmentalist and freelance writer. He is deeply committed to promoting... Nicholas Vincent is a passionate environmentalist and freelance writer. He is deeply committed to promoting sustainability and finding solutions to the most pressing environmental challenges of our time. In his free time, Nicholas enjoys the great outdoors and can often be found exploring some of the most beautiful and remote locations around the world. Read more about Nicholas Vincent Read More
A breakthrough treatment has allegedly cured a 21-year-old man’s sickle cell anemia—but its $3.1 million price tag puts it far out of reach for most patients. Lyfgenia, a gene therapy developed by Bluebird Bio, could transform countless lives. But unless the price is dramatically lowered, this revolutionary medicine will remain a luxury for the wealthy, not a lifeline for the many.
Sickle cell disease, affecting mainly Black and Hispanic communities, causes intense pain, organ damage, and early death. The cure exists. Yet, millions still suffer because they can’t afford it.
This is a matter of justice, not just science. Sign the petition now to demand that Bluebird Bio slash the price of Lyfgenia. Urge the FDA to ensure this treatment is accessible to all—not just the privileged few.
Sign the petition now. Lives are on the line.
Sign These Urgent Petitions!
Get your favorite articles delivered right to your inbox! Sign up for daily news from OneGreenPlanet.
Help keep One Green Planet free and independent! Together we can ensure our platform remains a hub for empowering ideas committed to fighting for a sustainable, healthy, and compassionate world. Please support us in keeping our mission strong.
Comments: